Risk Factors for Poor Tolerance of Ureteral Double-J Stent

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06815107

Acronym

ToleJJ

Enrollment

200

Registered

2025-02-07

Start date

2020-04-15

Completion date

2030-04-01

Last updated

2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tolerance, Ureteral Double-J Stent, Urinary Symptoms

Keywords

Ureteral Double-J Stent, tolerance, urinary symptom

Brief summary

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

Interventions

OTHERquestionnary

On day 1 of an ureteral double J stenting, each participant will receive the first USSQ questionnaire, in the French validated version. This questionnaire will be completed at home, one week after the intervention and returned at the following consultation or hospitalization.

OTHERUSSQ survey

if the stent is removed less than 6 months later, the second USSQ survey, in the French validated version will be given to the patient when removing the stent. This questionnaire will be completed at home one week after removal of the stent and return to the referent hospital. If the patient does not return the second questionnaire, our team may contact them by phone to complete it.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient over 18 years old * patient who need Ureteral Double-J Stenting

Exclusion criteria

* patient under 18 years old, * Iterative change, * understanding disorder, * inability to answer the questionnaire, * refusal of the patient, * long-term Ureteral Double-J Stenting (more than 6 month), * active cancer.

Design outcomes

Primary

Measure	Time frame	Description
tolerance score of Ureteral Double-J Stent	day 15	A tolerance score of Ureteral Double-J Stent will be established using the USSQ questionnaire allowing the comparison of the symptomatology with and after ablation of the stent

Countries

France

Contacts

CONTACTPhilippe De Sousa, MD

desousa.philippe@chu-amiens.fr33+322455775

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026